Gold nanoparticles as physiological markers of urine internalization into urothelial cells in vivo

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3945-3953

  Hudoklin, Samo ^a   Zupančič, Daša ^a   Makovec, Darko ^b   Kreft, Mateja Erdani ^a   Romih, Rok ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cancer models; Electron microscopy; Gold nanoparticles; Membrane internalization; Urinary bladder; Urothelial plaques

Indexed keywords

GOLD NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM VESICLE; CYTOSOL; DYSPLASIA; ENDOCYTOSIS; ENDOSOME; FUSIFORM VESICLE; HYPERPLASIA; IN VIVO STUDY; INTERNALIZATION; MALE; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; URINE; UROTHELIUM;

CANCER MODELS; ELECTRON MICROSCOPY; GOLD NANOPARTICLES; MEMBRANE INTERNALIZATION; URINARY BLADDER; UROTHELIAL PLAQUES;

ANIMALS; GOLD; INJECTIONS, INTRAVENOUS; MALE; METAL NANOPARTICLES; MICE; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84885767532     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44363     Document Type: Article

References (51)

1. Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol. 1997;13(5):291-298.
2. Hicks RM. The mammalian urinary bladder: an accommodating organ. Biol Rev Camb Philos Soc. 1975;50(2):215-246.
3. Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004;5(3):117-128.
4. Kreft ME, Hudoklin S, Jezernik K, Romih R. Formation and maintenance of blood-urine barrier in urothelium. Protoplasma. 2010;246(1-4):3-14.
5. Hicks RM. The fine structure of the transitional epithelium of rat ureter. J Cell Biol. 1965;26(1):25-48.
6. Kachar B, Liang F, Lins U, et al. Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol. 1999;285(2): 595-608.
7. Min G, Wang H, Sun TT, Kong XP. Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution. J Cell Biol. 2006;173(6):975-983.
8. Porter KR, Kenyon K, Badenhausen S. Specializations of the unit membrane. Protoplasma. 1967;63(1):262-274.
9. Veranic P, Romih R, Jezernik K. What determines differentiation of urothelial umbrella cells? Eur J Cell Biol. 2004;83(1):27-34.
10. Wu XR, Manabe M, Yu J, Sun TT. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem. 1990;265(31):19170-19179.
11. Yu J, Manabe M, Wu XR, Xu C, Surya B, Sun TT. Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol. 1990;111(3):1207-1216.
12. Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol. 1996;271(4 Pt 2):F886-F894.
13. Zocher F, Zeidel ML, Missner A, et al. Uroplakins do not restrict CO2 transport through urothelium. J Biol Chem. 2012;287(14): 11011-11017.
14. Wu RL, Osman I, Wu XR, et al.Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res. 1998;58(6):1291-1297.
15. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005;5(9):713-725.
16. Zupančič D, Ovčak Z, Vidmar G, Romih R. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Virchows Arch. 2011;458(5):603-613.
17. Zupančič D, Zakrajšek M, Zhou G, Romih R. Expression and localization of four uroplakins in urothelial preneoplastic lesions. Histochem Cell Biol. 2011;136(4):491-500.
18. Kreft ME, Jezernik K, Kreft M, Romih R. Apical plasma membrane traffic in superficial cells of bladder urothelium. Ann N Y Acad Sci. 2009;1152:18-29.
19. Wu XR, Kong XP, Pellicer A, Kreibich G, Sun TT. Uroplakins in urothelial biology, function, and disease. Kidney Int. 2009;75(11):1153-1165.
20. Derganc J, Božič B, Romih R. Shapes of discoid intracellular compartments with small relative volumes. PLoS ONE. 2011;6(11): e26824.
21. Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Electron tomography of fusiform vesicles and their organization in urothelial cells. PLoS ONE. 2012;7(3):e32935.
22. Erathodiyil N, Ying JY. Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res. 2011;44(10):925-935.
23. Bhattacharya R, Mukherjee P. Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev. 2008;60(11):1289-1306.
24. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumors. Pathology and genetic of tumors of the urinary system and male genital organs. Lyon, France: IARC Press; 2004.
25. Tokuyasu KT. A technique for ultracryotomy of cell suspensions and tissues. J Cell Biol. 1973;57(2):551-565.
26. Kreft ME, Hudoklin S, Sterle M. Establishment and characterization of primary and subsequent subcultures of normal mouse urothelial cells. Folia Biol (Praha). 2005;51(5):126-132.
27. Višnjar T, Kocbek P, Kreft ME. Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance. Histochem Cell Biol. 2012;137(2):177-186.
28. Bakri SJ, Pulido JS, Mukherjee P, Marler RJ, Mukhopadhyay D. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina (Philadelphia, Pa). 2008;28(1):147-149.
29. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325-327.
30. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15(4):897-900.
31. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79(939):248-253.
32. Mukherjee P, Bhattacharya R, Bone N, et al. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology. 2007;5:4.
33. Humbel BM, Sibon OC, Stierhof YD, Schwarz H. Ultra-small gold particles and silver enhancement as a detection system in immunolabeling and in situ hybridization experiments. J Histochem Cytochem. 1995;43(7):735-737.
34. Burry RW, Vandré DD, Hayes DM. Silver enhancement of gold antibody probes in pre-embedding electron microscopic immunocytochemistry. J Histochem Cytochem. 1992;40(12):1849-1856.
35. Baschong W, Stierhof YD. Preparation, use, and enlargement of ultrasmall gold particles in immunoelectron microscopy. Microsc Res Tech. 1998;42(1):66-79.
36. Hainfeld JF, Powell RD. New frontiers in gold labeling. J Histochem Cytochem. 2000;48(4):471-480.
37. Yu W, Khandelwal P, Apodaca G. Distinct apical and basolateral membrane requirements for stretch-induced membrane traffic at the apical surface of bladder umbrella cells. Mol Biol Cell. 2009;20(1): 282-295.
38. Kreft ME, Romih R, Kreft M, Jezernik K. Endocytotic activity of bladder superficial urothelial cells is inversely related to their differentiation stage. Differentiation. 2009;77(1):48-59.
39. Cooper EH. The biology of bladder cancer. Ann R Coll Surg Engl. 1972;51(1):1-16.
40. Martin BF. Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. J Anat. 1972;112(Pt 3):433-455.
41. Erman A, Zupancic D, Jezernik K. Apoptosis and desquamation of urothelial cells in tissue remodeling during rat postnatal development. J Histochem Cytochem. 2009;57(8):721-730.
42. Veranic P, Erman A, Kerec-Kos M, Bogataj M, Mrhar A, Jezernik K. Rapid differentiation of superficial urothelial cells after chitosan-induced desquamation. Histochem Cell Biol. 2009;131(1):129-139.
43. Korosec P, Jezernik K. Early cellular and ultrastructural response of the mouse urinary bladder urothelium to ischemia. Virchows Arch. 2000;436(4):377-383.
44. Veranic P, Jezernik K. Succession of events in desquamation of superficial urothelial cells as a response to stress induced by prolonged constant illumination. Tissue Cell. 2001;33(3):280-285.
45. Arai M, Kani T, Sugihara S, et al. Scanning and transmission electron microscopy of changes in the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosoamine. Gann. 1974;65(6):529-540.
46. Ariel I, Ayesh S, Gofrit O, et al. Gene expression in the bladder carcinoma rat model. Mol Carcinog. 2004;41(2):69-76.
47. Hu P, Meyers S, Liang FX, et al. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol Renal Physiol. 2002;283(6):F1200-F1207.
48. Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA. Beating cancer in multiple ways using nanogold. Chem Soc Rev. 2011;40(7): 3391-3404.
49. Jain KK. Advances in the field of nanooncology. BMC Med. 2010;8:83.
50. Jain S, Hirst DG, O'Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012;85(1010):101-113.
51. Thurn KT, Brown E, Wu A, et al. Nanoparticles for applications in cellular imaging. Nanoscale Res Lett. 2007;2(9):430-441.